Rchr
J-GLOBAL ID:202201016469802650
Update date: Nov. 05, 2024
Yoshida Yuichi
ヨシダ ユウイチ | Yoshida Yuichi
Affiliation and department:
Research theme for competitive and other funds (2):
- 2017 - 2020 Circular microRNA profiles as biomarkers for early stage hepatocellular carcinoma in patients infected with hepatitis B virus
- 2015 - 2019 Investigation of the initial immune-responsiveness and memory immunity to the hepatitis B vaccine
Papers (71):
-
Hidekatsu Kuroda, Tamami Abe, Naohisa Kamiyama, Takuma Oguri, Asami Ito, Ippeki Nakaya, Takuya Watanabe, Hiroaki Abe, Kenji Yusa, Yudai Fujiwara, et al. Novel subharmonic-aided pressure estimation for identifying high-risk esophagogastric varices. Journal of gastroenterology. 2024
-
Keisuke Kakisaka, Takuya Watanabe, Yuichi Yoshida, Hiroaki Abe, Kenji Yusa, Tokio Sasaki, Yudai Fujiwara, Tamami Abe, Akiko Suzuki, Kei Endo, et al. Body mass index of 23 or greater is relevant to hepatic steatosis and fibrosis in patients with harmful alcohol use. Hepatology research : the official journal of the Japan Society of Hepatology. 2024
-
Yudai Fujiwara, Hidekatsu Kuroda, Tamami Abe, Keisuke Kakisaka, Ippeki Nakaya, Asami Ito, Takuya Watanabe, Kenji Yusa, Tomoaki Nagasawa, Hiroki Sato, et al. Early Clinical Outcomes of Durvalumab Plus Tremelimumab in Unresectable Hepatocellular Carcinoma: A Real-World Comparison with First-Line or Later-Line Treatment. Drugs - real world outcomes. 2024
-
Kei Endo, Keisuke Kakisaka, Tamami Abe, Kenji Yusa, Ippeki Nakaya, Takuya Watanabe, Hiroaki Abe, Akiko Suzuki, Yuichi Yoshida, Takayoshi Oikawa, et al. Grip strength complements performance status in assessing general condition in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab. Hepatology research : the official journal of the Japan Society of Hepatology. 2024
-
Keisuke Kakisaka, Tokio Sasaki, Ippeki Nakaya, Takuya Watanabe, Hiroaki Abe, Kenji Yusa, Yudai Fujiwara, Tamami Abe, Akiko Suzuki, Kei Endo, et al. Low liver reserve is a risk factor for acute pancreatitis in patients with acute liver failure. Hepatology research : the official journal of the Japan Society of Hepatology. 2024
more...
MISC (88):
-
吉田 雄一, 宮坂 昭生, 滝川 康裕. 日本の肝がん死の減少を目指して-受検・受診・受療・フォローのCascade of care(疫学・政策) 透析患者におけるmicro-elimination of HCVの現状と課題. 肝臓. 2022. 63. Suppl.1. A182-A182
-
宮坂 昭生, 吉田 雄一, 鈴木 彰子, 滝川 康裕. 実臨床におけるGenotype 1型C型肝炎に対するエルバスビル・グラゾプレビルの治療効果と安全性(The efficacy and safety of elbasvir and grazoprevir for hepatitis C virus genotype 1 in a real clinical setting). 岩手医学雑誌. 2022. 74. 1. 11-19
-
吉田 雄一, 宮坂 昭生, 滝川 康裕. C型肝炎:今後の課題と対策 C型肝炎の検査結果の説明と治療導入に関する医療機関へのアンケート調査. 日本消化器病学会雑誌. 2022. 119. 臨増総会. A73-A73
-
柿坂 啓介, 吉田 雄一, 鈴木 悠地, 滝川 康裕. 自己免疫性肝疾患患者への新型コロナウイルス予防接種に関する情報提供の心理的効果についての検討. 肝臓. 2021. 62. Suppl.3. A725-A725
-
柿坂 啓介, 鈴木 悠也, 吉田 雄一, 滝川 康裕. 自己免疫性肝疾患患者への新型コロナウイルスワクチン接種に関する情報提供による心理的影響. 肝臓. 2021. 62. 10. 613-619
more...
Return to Previous Page